Song, Washington, Crawford: "Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer." in: Cancer research, Vol. 70, Issue 5, pp. 2115-25, 2010 (PubMed).
Bernardo, Lozada, Miedler et al.: "FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis." in: Development (Cambridge, England), Vol. 137, Issue 12, pp. 2045-54, 2010 (PubMed).
Zhang, Liang, Li et al.: "CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen." in: The Journal of biological chemistry, Vol. 285, Issue 37, pp. 28604-13, 2010 (PubMed).
Hu, Gardner-Stephen, Severi et al.: "A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide." in: Molecular pharmacology, Vol. 78, Issue 4, pp. 714-22, 2010 (PubMed).
Liu, Niu, Wang et al.: "[Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas]." in: Zhonghua yi xue za zhi, Vol. 90, Issue 20, pp. 1403-7, 2010 (PubMed).